| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |